Raymond James Financial Services Advisors, Inc. Avidity Biosciences, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 115,403 shares of RNA stock, worth $3.08 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
115,403
Previous 112,033
3.01%
Holding current value
$3.08 Million
Previous $4.58 Million
15.82%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding RNA
# of Institutions
258Shares Held
100MCall Options Held
517KPut Options Held
717K-
Price T Rowe Associates Inc Baltimore, MD11MShares$294 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.43MShares$251 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$230 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.93MShares$211 Million3.76% of portfolio
-
Avoro Capital Advisors LLC New York, NY7.5MShares$200 Million3.18% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.39B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...